The outlook of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key regions has introduced substantial risk . Investors are now facing the impact of rival medications , reduced income ,